Imatinib-d8 is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity[1][2].
Molecular Weight:
501.65
Purity:
99.85
CAS Number:
[1092942-82-9]
Formula:
C29H23D8N7O
Target:
Autophagy,Bcr-Abl,c-Kit,PDGFR,SARS-CoV
Application Notes:
Isotope-Labeled Compounds
* VAT and and shipping costs not included. Errors and price changes excepted
